Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

MICONAZOLE CRS (50 MG)

MICONAZOLE CRS (50 MG)

22916-47-8

DISCOVER
MICONAZOLE NITRATE CRS (100 MG)

MICONAZOLE NITRATE CRS (100 MG)

22832-87-7

DISCOVER
Methenolone Acétate

Methenolone Acétate

434-05-9

DISCOVER
Molsidomine Impurity A

Molsidomine Impurity A

16142-27-1

DISCOVER
MIDAZOLAM CRS - * PSY (50 MG)

MIDAZOLAM CRS - * PSY (50 MG)

59467-70-8

DISCOVER
Methacholine Chloride

Methacholine Chloride

62-51-1

DISCOVER
Rac-Monepantel

Rac-Monepantel

851976-50-6

DISCOVER
MINOXIDIL CRS (50 MG)

MINOXIDIL CRS (50 MG)

38304-91-5

DISCOVER
MITOXANTRONE HYDROCHLORIDE CRS (60 MG)

MITOXANTRONE HYDROCHLORIDE CRS (60 MG)

70476-82-3

DISCOVER
MITOXANTRONE IMPURITY A CRS (5 MG)

MITOXANTRONE IMPURITY A CRS (5 MG)

NA

DISCOVER
Monepantel Sulfone

Monepantel Sulfone

851976-52-8

DISCOVER
Marbofloxacin

Marbofloxacin

115550-35-1

DISCOVER